Skip to content

Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity

Study of the Role of Insulin Resistance in the Pathogenesis of the Metabolic Syndrome and of Non-alcoholic Steatohepatitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00523562
Acronym
MACRONUTR
Enrollment
41
Registered
2007-08-31
Start date
2006-07-31
Completion date
2009-01-31
Last updated
2018-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Metabolic Syndrome X

Keywords

fructose, dietary lipids, dietary proteins, hepatic steatosis, insulin resistance, Healthy humans, overweight humans, obese humans

Brief summary

The purpose of this study is to assess how the macronutrient composition of the diet effects * lipid and glucose metabolism * intrahepatic lipids * insulin sensitivity in healthy lean subjects and in subjects with a high metabolic risk (ie overweight and offsprings of patients with type 2 diabetes mellitus).

Detailed description

The study is aimed at assessing the effects of changes in total energy, sugars, lipids, and protein intake on intrahepatic lipids, plasma lipids, and hepatic and whole body insulin resistance in * lean men and women with no family history of diabetes * overweight men and women * lean men with a family history of type 2 diabetes Subjects are studied after a 6-day period of * isocaloric diet with 100% calorie requirement, of which 55% carbohydrate, 15% protein, and 30% fat) * the same isocaloric diet supplemented with 3g/kg body weight/day fructose * hypercaloric high fat diet with 130% energy requirement, of which 55% carbohydrate, 15% protein, 60% fat * hypercaloric high fat+protein diet with 145% energy requirement, of which 55% carbohydrate, 30% protein, 60% fat Measurements performed after 6 days on each diet include * intrahepatic and intramyocellular lipids (1H-MRS) * hepatic and whole body insulin sensitivity (hyperinsulinemic-euglycemic clamp) * body weight * plasma concentrations of hormones and substrates * gene expression profile in skeletal muscle (vastus lateralis) and adipose tissue (subcutaneous abdominal)

Interventions

OTHERdiet intervention

controlled hypercaloric high fructose, high fat, or high fat/high protein diet

Sponsors

University of Lausanne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females * Age 18-40 * Informed consent obtained * Subgroup with overweight (body mass index \[BMI\] \> 25) * Subgroup with family history of type 2 diabetes mellitus

Exclusion criteria

* Smokers * Alcohol intake \> 30g/day * Drug abuse * Diabetes mellitus * Any concurrent medication * Having a pacemaker * History of orthopedic surgery * History of metal foreign bodies

Design outcomes

Primary

MeasureTime frame
plasma triglycerides6 days
intra-hepatic lipids6 days
insulin mediated glucose disposal6 days

Secondary

MeasureTime frame
lipid oxidation6 days
plasma beta-hydroxybutyrate6 days
gene expression in skeletal muscle and adipose tissue6 days

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026